217 related articles for article (PubMed ID: 31447895)
1. Approach to a patient with cardiac amyloidosis.
Strouse C; Briasoulis A; Fonseca R; Jethava Y
J Geriatr Cardiol; 2019 Jul; 16(7):567-574. PubMed ID: 31447895
[No Abstract] [Full Text] [Related]
2. A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies.
Raval M; Siddiq S; Sharma K; Sanghvi L; Jain A; Patel S; Trivedi J; Uttam Chandani K; Patel D; Desai R
F1000Res; 2023; 12():192. PubMed ID: 36911240
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States.
Gilstrap LG; Dominici F; Wang Y; El-Sady MS; Singh A; Di Carli MF; Falk RH; Dorbala S
Circ Heart Fail; 2019 Jun; 12(6):e005407. PubMed ID: 31170802
[TBL] [Abstract][Full Text] [Related]
4. Cardiac amyloidosis-an underdiagnosed cause of heart failure in the elderly.
Nazir T; Nuffati M
J Saudi Heart Assoc; 2020; 32(1):98-102. PubMed ID: 33154899
[TBL] [Abstract][Full Text] [Related]
5. Recognition of congestive heart failure due to senile cardiac amyloidosis.
Gertz MA; Kyle RA; Edwards WD
Biomed Pharmacother; 1989; 43(2):101-6. PubMed ID: 2736272
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic testing to guide vasodilator therapy in cardiac amyloidosis.
Rucker DM; Siddiqi OK; Pimentel DR; Luptak I
J Cardiol Cases; 2023 Sep; 28(3):105-108. PubMed ID: 37671260
[TBL] [Abstract][Full Text] [Related]
7. Intracardiac Thrombosis and Heart Failure in a Patient with Hepatocellular Carcinoma and Cardiac Amyloidosis and an Implanted Cardiac Resynchronization Therapy Device.
Akutsu Y; Kawamura M; Tanisawa H; Nomura K; Gokan T; Sekimoto T; Kaneko K; Kodama Y; Ohgiya Y; Matsuyama T; Gokan T; Shinke T
Am J Case Rep; 2019 Jun; 20():933-936. PubMed ID: 31256189
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Strategy for Heart Failure with Reduced Ejection Fraction and Cardiac Amyloidosis.
Imamura T; Izumida T; Nakamura M; Kinugawa K
Int Heart J; 2022; 63(2):408-410. PubMed ID: 35354759
[TBL] [Abstract][Full Text] [Related]
9. Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.
Estep JD; Bhimaraj A; Cordero-Reyes AM; Bruckner B; Loebe M; Torre-Amione G
Methodist Debakey Cardiovasc J; 2012; 8(3):8-16. PubMed ID: 23227279
[TBL] [Abstract][Full Text] [Related]
10. Cardiac amyloidosis presenting as sick sinus syndrome and intractable heart failure: report of a case.
Hwang YT; Tseng CD; Hwang JJ; Hsu KL; Chiang FT; Tseng YZ; How SW
J Formos Med Assoc; 1993 Mar; 92(3):283-7. PubMed ID: 8102285
[TBL] [Abstract][Full Text] [Related]
11. [Problems of diagnostics and treatment of transtiretinum amyloidosis with destruction of the heart in the elderly: Clinical experience.].
Boldueva SA; Petrova VB; Khavinson VK; Samohvalova MV; Petrova AI
Adv Gerontol; 2019; 32(1-2):137-144. PubMed ID: 31228380
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight.
Logothetis CN; Fernandez J; Laber DA
Case Rep Med; 2021; 2021():2551964. PubMed ID: 34917152
[TBL] [Abstract][Full Text] [Related]
13. [The Changing Appearance of Cardiac Amyloidosis].
Mahrholdt H; Klingel K; Sechtem U
Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
[TBL] [Abstract][Full Text] [Related]
14. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
[TBL] [Abstract][Full Text] [Related]
15. Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
Okamoto N; Kubo T; Nakashima Y; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kitaoka H
Intern Med; 2020 Feb; 59(3):339-343. PubMed ID: 31588087
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with cardiac amyloidosis.
Goeminne A; Missault L; Bauwens F; De Pauw M; De Sutter J
Acta Cardiol; 2003 Apr; 58(2):143-7. PubMed ID: 12715906
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic approach to cardiac amyloidosis.
Amin HZ; Mori S; Sasaki N; Hirata K
Kobe J Med Sci; 2014 Jun; 60(1):E5-E11. PubMed ID: 25011639
[TBL] [Abstract][Full Text] [Related]
18. Cardiac amyloidosis-An underdiagnosed cause of heart failure: A case report and review of literature.
Parmar K; Benjanuwattra J; Sethi P; Tijani L; Hurst P; Pertuz GD; Argueta-Sosa E
Clin Case Rep; 2022 Dec; 10(12):e6525. PubMed ID: 36478969
[TBL] [Abstract][Full Text] [Related]
19. Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.
Dey BR; Chung SS; Spitzer TR; Zheng H; Macgillivray TE; Seldin DC; McAfee S; Ballen K; Attar E; Wang T; Shin J; Newton-Cheh C; Moore S; Sanchorawala V; Skinner M; Madsen JC; Semigran MJ
Transplantation; 2010 Oct; 90(8):905-11. PubMed ID: 20733534
[TBL] [Abstract][Full Text] [Related]
20. Molecular Imaging of Cardiac Amyloidosis.
Pelletier-Galarneau M; Abikhzer G; Giraldeau G; Harel F
Curr Cardiol Rep; 2019 Feb; 21(3):12. PubMed ID: 30815746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
